The expression of central 5-HT1A and 5-HT1B receptors was studied in several brain areas of rats subjected to a 2-week period of chronic alcoholization, followed by 18 h withdrawal. Quantitative autoradiography indicated that the ethanol treatment provoked an increase (approximately +30%) in the labeling by [3H]8-hydroxy-2-(di-n-propylamino)tetralin ([3H]8-OH-DPAT) and [3H]N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexane carboxamide ([3H]WAY-100635) of 5-HT1A autoreceptors in the dorsal raphe nucleus, accompanied by a concomitant decrease in the labeling of postsynaptic 5-HT1A receptors in the hippocampus (approximately -20%), anterior (approximately -30%) and posterior (approximately -32%) cortices. These changes were associated with a tendency toward an increase and decrease in 5-HT1A mRNA levels in the anterior raphe area and hippocampus, respectively, suggesting that the changes observed are due to modifications in 5-HT1A receptor protein synthesis. The autoradiographic labeling of 5-HT1B receptors by serotonin-O-carboxymethylglycyl[125I]iodotyrosinamide ([125I]GTI) was found to increase (+55%) in the globus pallidus of alcoholized rats. Interestingly, a significant increase (+57%) in 5-HT1B receptor mRNA levels was observed in the striatum, which contains cell bodies of neurons projecting into the globus pallidus. These data suggest that altered sensitivity of chronically alcoholized rats to 5-HT1A and 5-HT1B receptor ligands may result from alcohol-induced changes in the transcription of the genes encoding these receptors.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0014-2999(95)00238-g | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vortioxetine-Induced Bleeding Tendency in a Young Woman with Depression: A Case Report.
Psychiatry Clin Psychopharmacol
November 2024
Department of Psychiatry and Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Vortioxetine, which functions as a 5-HT3, 5-HT1D, and 5-HT7 antagonist, a 5-HT1A agonist, and a 5-HT1B partial agonist, is a recently launched antidepressant approved by the United States Food and Drug Administration for treating adult major depressive disorder. Although hematological adverse effects have been associated with antidepressants, massive bleeding is a rare but potentially life-threatening complication. In this case report, we present a young woman who experienced abnormal bleeding tendencies, with manifestations including tarry stools, ecchymosis, and massive uterine bleeding, while undergoing vortioxetine treatment.
View Article and Find Full Text PDFSerotonin suppresses intraspecific aggression in an agrobiont spider, Pardosa pseudoannulata, without affecting predation on insects.
Insect Sci
October 2024
Key Laboratory of Integrated Management of Crop Diseases and Pests (Ministry of Education), College of Plant Protection, Nanjing Agricultural University, Nanjing, China.
Article Synopsis
- Spiders are important natural predators of insect pests, but their use in biological pest control is limited due to challenges in mass production, particularly intense aggression among individuals.
- This study investigates how serotonin (5-HT) affects aggression in the wandering spider Pardosa pseudoannulata, finding that manipulating serotonin levels can decrease aggression, with specific 5-HT receptors having distinct effects on aggressive behaviors.
- The research suggests that understanding serotonin's role in aggression can help develop strategies for reducing spider aggression, which is essential for their successful mass rearing and use in pest control without affecting their predation abilities.
Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis.
Curr Neuropharmacol
September 2024
IRCSS Neuromed, Pozzilli (IS), Italy.
Article Synopsis
- * Traditional antidepressants can cause unwanted side effects like weight gain and sexual dysfunction, making them less suitable for some MS patients.
- * Vortioxetine, a new antidepressant with a unique mechanism, may improve symptoms of depression and anxiety in MS patients and could have additional benefits due to its possible anti-inflammatory properties; however, more specific research on its effectiveness in MS is needed.
Reduced serotonergic transmission alters sensitivity to cost and reward via 5-HT1A and 5-HT1B receptors in monkeys.
PLoS Biol
January 2024
Department of Functional Brain Imaging, National Institutes for Quantum Science and Technology, Chiba, Japan.
Serotonin (5-HT) deficiency is a core biological pathology underlying depression and other psychiatric disorders whose key symptoms include decreased motivation. However, the exact role of 5-HT in motivation remains controversial and elusive. Here, we pharmacologically manipulated the 5-HT system in macaque monkeys and quantified the effects on motivation for goal-directed actions in terms of incentives and costs.
View Article and Find Full Text PDFExploring Next-Generation Therapeutics: Morphic Mixtures and Specified Salts for the Treatment of Mental Disorders and CNS Modulation.
ACS Med Chem Lett
September 2023
Usona Institute, Fitchburg, Wisconsin 53711-5300, United States.
This Patent Highlight delves into the potential of next-generation therapeutics for treating mental disorders and modulating the central nervous system (CNS). Among the serotonin receptor subtypes, 5-HT2A, 5-HT2C, 5-HT1A, and 5-HT1B have shown promise in CNS disorder treatment. Approved drugs targeting these receptors, such as antipsychotics and psychedelics, provide valuable insights into their therapeutic effects.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!